Trillium Therapeutics Reports Annual Financial and Operating Results

NEXT STORY
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
PREV STORY
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AIT Therapeutics Reports Financial Results for Fiscal Second Quarter 2019

PMA filing for treatment of PPHN expected in calendar second quarter 2019 Pivotal Bronchiolitis ...

author_avatar
NASDAQ Market News

BeyondSpring Announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data Showing Plinabulin, in Combination with Pegfilgrastim, Reverses the Immune-Suppressive Effects of Pegfilgrastim and Offers Superior Prevention of Chemotherapy-Induced Neutropenia (CIN) at the FOCIS Annual Meeting

author_avatar
NASDAQ Market News

Jordan Barnett, M.D., is Honored by the American Health Council for Best in Medicine

NEW YORK, July 06, 2017 (GLOBE NEWSWIRE) -- With a diverse educational background in ...

author_avatar
NASDAQ Market News